Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Eggcellent is a biotechnology and food-tech company based in Israel that specializes in the upcycling of eggshell waste into high-value nutritional and pharmaceutical-grade ingredients. The company has developed a proprietary, eco-friendly technology to separate and extract calcium and functional proteins, specifically collagen (Types I and X), from eggshells and their inner membranes. These bio-available materials are intended for use in the nutraceutical, cosmetic, and healthcare sectors to support bone health, joint function, and skin rejuvenation. By transforming industrial food waste into premium ingredients, Eggcellent addresses the growing demand for sustainable, circular-economy solutions in the life sciences industry. The company operates within the Fresh Start FoodTech incubator and is supported by a consortium of global investors and industry leaders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eggcellent Proteins.